Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway

Cancer Letters
Chye-Sun OngHan-Ming Shen

Abstract

Luteolin, a plant flavonoid is known to possess multiple biological activities such as anti-inflammation, anti-allergy, anti-oxidant as well as anti-cancer. At present, the anti-proliferative potential of luteolin has not been fully understood. In this study, we focused on the effect of luteolin on cell cycle regulation in human nasopharyngeal carcinoma (NPC) cells. First, we found that luteolin inhibited cell cycle progression at G1 phase and prevented entry into S phase in a dose- and time-dependent manner. Next, it was found that luteolin treatment led to down-regulation of cyclin D1 via enhanced protein phosphorylation and proteasomal degradation, leading to reduced CDK4/6 activity and suppression of retinoblastoma protein (Rb) phosphorylation, and subsequently inhibition of the transcription factor E2F-1. In search of the molecular mechanisms underlying luteolin-mediated cyclin D1 down-regulation, it was found that luteolin was capable of suppressing Akt phosphorylation and activation, resulting in de-phosphorylation and activation of glycogen synthase kinase-3β (GSK-3β). Activated GSK-3β then targeted cyclin D1, causing phosphorylation of cyclin D1 at Thr(286) and subsequent proteasomal degradation. The above findings wer...Continue Reading

References

Apr 1, 1995·International Journal of Epidemiology·A J HanleyE J Holowaty
Feb 16, 2002·Cellular and Molecular Life Sciences : CMLS·A J Obaya, J M Sedivy
Nov 15, 2002·Cancer Biology & Therapy·J Alan Diehl
Apr 8, 2003·Current Medicinal Chemistry. Anti-cancer Agents·M López-Lázaro
Jul 10, 2003·Cell Cycle·Jiyong Liang, Joyce M Slingerland
Feb 17, 2005·European Journal of Pharmacology·An-Chin ChengMin-Hsiung Pan
Jun 21, 2005·Biochemical and Biophysical Research Communications·Mano HorinakaToshiyuki Sakai
Sep 16, 2005·Journal of Cellular Biochemistry·Andrew B Gladden, J Alan Diehl
Nov 17, 2005·Oncogene·Deborah A Altomare, Joseph R Testa
Mar 7, 2006·Current Drug Targets·Rana Pratap Singh, Rajesh Agarwal
Aug 29, 2006·Oncogene·C Giacinti, A Giordano
Oct 3, 2006·Journal of Cellular Physiology·Yitao QiZongcan Zhou
Feb 27, 2007·The Journal of Nutritional Biochemistry·Sonia Ramos
Mar 16, 2007·Cancer Science·Etsu TashiroMasaya Imoto
Jul 14, 2007·Mini Reviews in Medicinal Chemistry·Yanling LiWenfang Xu
Feb 22, 2008·Current Cancer Drug Targets·Eriko TokunagaYoshihiko Maehara
Apr 10, 2008·Phytotherapy Research : PTR·Anup KaleSwati Kotwal
Apr 17, 2008·Cell Cycle·Stacy W Blain
May 1, 2008·Head & Neck·Josephine ChouDavid M Jablons
Oct 22, 2008·Planta medica·Günter SeelingerChristoph M Schempp
Oct 24, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Günter SeelingerChristoph M Schempp
Nov 11, 2008·Current Cancer Drug Targets·Yong LinHan-Ming Shen
Jan 20, 2009·Mini Reviews in Medicinal Chemistry·Miguel López-Lázaro
Feb 25, 2009·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
May 6, 2009·Journal of Cellular Physiology·Jong Kyong Kim, J Alan Diehl

❮ Previous
Next ❯

Citations

Aug 15, 2012·Journal of Nutrition in Gerontology and Geriatrics·Donato F Romagnolo, Ornella I Selmin
Jan 31, 2013·BMC Clinical Pathology·Dimitrios KrikelisGeorge Fountzilas
Apr 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jin-Yi WuYi-Wen Liu
May 24, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yi ZhangQifa Ye
Jan 16, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Ting-Ting WangGui-Ju Sun
Mar 12, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Yen-Chuan OuChun-Jung Chen
Dec 6, 2017·Molecular Medicine Reports·Guixia WuKurexi Yunusi
Nov 23, 2012·Phytotherapy Research : PTR·Ho Young KimHyong Joo Lee
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pei LiuXiaojun Yang
Jan 10, 2014·Cancer Prevention Research·Debatosh MajumdarDong M Shin
Apr 1, 2018·Cancer Prevention Research·Kyle CrookerSufi Mary Thomas
Apr 20, 2014·Molecular Cancer Therapeutics·Annett MadererMarkus Moehler
Jan 7, 2021·Antioxidants & Redox Signaling·Emiliano Panieri, Luciano Saso
Feb 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Muhammad ImranMohammad S Mubarak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

© 2021 Meta ULC. All rights reserved